NOT-DA-18-021: Notice of a Change to Award Project Period in RFA-DA-19-004,"Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24

Notice of a Change to Award Project Period in RFA-DA-19-004,"Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Clinical Trial Not Allowed)"

Notice Number: NOT-DA-18-021

Key Dates
Release Date: June 29, 2018

Related Announcements
RFA-DA-19-004

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

This Notice corrects the Award Project Period of Funding Opportunity (FOA) RFA-DA-19-004,"Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Clinical Trial Not Allowed)" from 3 years to 5 years.

Part 2. Section II. Award Information

Currently reads:

Award Project Period

The maximum project period is 3 years.

Modified to read:

Award Project Period

The maximum project period is 5 years.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Richard A. Jenkins, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-1923
Email: [email protected]